TrademarkDir
MULTIPLE THERAPIES, ONE VIRUS
LIVE

Serial Number

97150701

Owner

KALIVIR IMMUNOTHERAPEUTICS, INC.

Attorney

Draeke H. Weseman

First Use Date

Dec 7, 2020

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MULTIPLE THERAPIES, ONE VIRUS Trademark

Serial Number: 97150701 • Registration: 8128341

MULTIPLE THERAPIES, ONE VIRUS is a trademark filed by KALIVIR IMMUNOTHERAPEUTICS, INC. on December 1, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KALIVIR IMMUNOTHERAPEUTICS, INC. (9 trademarks)

240 Alpha Drive
Pittsburgh, PA 15238

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

February 3, 2026

First Use Anywhere

December 7, 2020

First Use in Commerce

December 7, 2020

Published for Opposition

October 18, 2022

Goods & Services

Medical and scientific research in the fields of immunotherapy, immunotherapeutics, biotechnology, and biopharmaceuticals; immunotherapeutic and biopharmaceutical drug development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 12, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 12, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 17, 2025 SUPC
USE AMENDMENT FILED
Dec 15, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 15, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 1, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 1, 2025 AITU
SOU TEAS EXTENSION RECEIVED
May 15, 2025 EEXT
SOU EXTENSION 5 FILED
May 14, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 10, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 10, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 3, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 3, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 7, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 7, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 7, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 12, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 13, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2022 CNSA
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP

Related Trademarks

More from this Owner

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

V.E.T. PLATFORM

V.E.T. PLATFORM

(KV) KALIVIR IMMUNOTHERAPEUTICS logo

(KV) KALIVIR IMMUNOTHERAPEUTICS

(KV) KALIVIR IMMUNOTHERAPEUTICS logo

(KV) KALIVIR IMMUNOTHERAPEUTICS

V.E.T. PLATFORM

V.E.T. PLATFORM